Graph Therapeutics

Graph TherapeuticsGraph Therapeutics
Graph Therapeutics

Graph Therapeutics

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Website
2021Active
Rate
Advertise here

About

Graph Therapeutics is a next-generation techbio company focused on developing precision medicines for inflammatory and immune-mediated diseases. They leverage a proprietary 'lab-in-the-loop' AI platform that combines perturbation modeling of live patient samples, functional and multi-omics profiling, and advanced machine learning to understand immune dysfunction at scale. By analyzing real patient tissue, Graph identifies disease mechanisms, novel therapeutic targets, and biomarkers to create differentiated therapies. The company has a validated platform and is advancing an internal pipeline of therapeutics, while also exploring strategic partnerships and out-licensing opportunities.

Technology stack

detected 2026-06-30
EmailGoogle Workspace
Stack
Framer
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Graph Therapeutics do?

Graph Therapeutics is a next-generation techbio company focused on developing precision medicines for inflammatory and immune-mediated diseases. They leverage a proprietary 'lab-in-the-loop' AI platform that combines perturbation modeling of live patient samples, functional and multi-omics profiling, and advanced machine learning to understand immune dysfunction at scale. By analyzing real patient tissue, Graph identifies disease mechanisms, novel therapeutic targets, and biomarkers to create di…

How much funding has Graph Therapeutics raised?

Graph Therapeutics has raised a total of $5M in funding. The most recent round on record is Funding Round.

Where is Graph Therapeutics headquartered?

Graph Therapeutics is headquartered in Austria.

When was Graph Therapeutics founded?

Graph Therapeutics was founded in 2021.

What industry does Graph Therapeutics operate in?

Graph Therapeutics operates in Biotechnology, Artificial Intelligence, Healthcare, Drug Discovery, Precision Medicine, Biotech.

What is Graph Therapeutics's revenue?

StartupHub estimates Graph Therapeutics's annual revenue at $612K (range $163K to $2.1M, 37% confidence), based on comparable companies in the sector.

What is Graph Therapeutics's valuation?

StartupHub estimates Graph Therapeutics's effective valuation at $18.3M (range $12.5M to $30.0M, 25% confidence), based on comparable companies in the sector.